Branch Retinal Vein Occlusion (BRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.

NCT04601688 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Branch Retinal Vein Occlusion

Interventions

DRUG: Bevacizumab Ophthalmic and Intravitreal Dexamethasone
DRUG: Bevacizumab Ophthalmic

Sponsor

He Eye Hospital